杭州九源基因生物医药股份有限公司（“九源基因”，02566）于2026年3月18日披露2026年1月股份变动月报表，报告期为2026年1月。
截至本月末，公司注册股本人民币245,398,800元，其中包括三类股份：H股、内资股及非上市外资股。H股方面，月初已发行流通股份数量为109,096,785股，当月合计回购774,400股，并将其持作库存股份，导致H股流通股份减少至108,322,385股，库存股份则增至774,400股。内资股和非上市外资股数量分别维持在105,302,015股及31,000,000股，报告期内无变动。
本月内无新增发行股份，无注销股份，也无任何股份期权、可换股票据或其他股权激励计划变动。公司确认遵守香港联交所《上市规则》等相关法律法规。截至1月末，公司股本总数保持稳定。
本次公告由联席公司秘书黄秀签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.